NCT05219760

Brief Summary

The investigators aim to compare the efficacy of an IBI targeting complicated grief symptoms (LIVIA 2.0) compared to an already investigated IBI (LIVIA 1) using a guidance on demand design in a randomised controlled trial (RCT). More specifically, the investigators will test the following primary hypotheses:

  • Both interventions will significantly increase participants' well-being and decrease their distress, and those changes will be stable until follow-up.
  • LIVIA 2.0 will be more efficient than LIVIA 1 on all measure outcomes.
  • LIVIA 2.0 will have less dropouts than LIVIA 1.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 23, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 2, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

May 6, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 10, 2023

Completed
Last Updated

September 8, 2023

Status Verified

September 1, 2023

Enrollment Period

9 months

First QC Date

December 23, 2021

Last Update Submit

September 7, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in complicated grief symptoms

    assessed with a French version (Cherblanc \& Zech, 2021) of The Traumatic Grief Inventory (Boelen et al., 2019), on a scale ranging from 1 = never to 5 = always. The mean score is used as a final score. Higher score represent a higher symptom load.

    Pretest; 12-week post-test; 3-month Follow-up

  • Change in depression symptoms

    assessed with the Patient Health Questionnaire-9 (Kroenke \& Spitzer, 2002; Kroenke, Spitzer \& Williams, 2001), on a scale ranging from 0 = never to 4 = practically every day. The sum of the scores is used as a final score. Higher score represent a higher symptom load.

    Pretest; 12-week post-test; 3-month Follow-up

  • Change in well-being

    measured with the French version (Villieux et al., 2016) of the Flourishing Scale (Diener et al., 2010), on a scale ranging from 1 = I completely disagree, to 7 = I completely agree. The mean score is used as a final score. Higher score represent a better psychological well-being.

    Pretest; 12-week post-test; 3-month Follow-up

Secondary Outcomes (7)

  • Change in anxiety symptoms

    Pretest; 12-week post-test; 3-month Follow-up

  • Change in grief coping strategies

    Pretest; 12-week post-test; 3-month Follow-up

  • Change in aspects related to identity

    Pretest; 12-week post-test; 3-month Follow-up

  • Satisfaction with the program (utility, clarity, impact, etc.) assessed by an adapted version of the CSQ-I

    12-week post-test

  • Change in the monitoring of the mood, solitude feelings and grief symptoms

    Days 1, 8, 15, 22, 29, 36, 43, 50, 57, 64, 71, 78, 85

  • +2 more secondary outcomes

Study Arms (2)

LIVIA 1

ACTIVE COMPARATOR

LIVIA 1 is a 12-week intervention composed of 10 sessions, whereby we recommend completing one session per week. It includes psychoeducational content and exercises that are based on empirically validated intervention tools, mainly issued from Cognitive-Behavioral Therapy.

Device: LIVIA

LIVIA 2.0

EXPERIMENTAL

LIVIA 2.0 is a 12-week intervention composed of 10 sessions, whereby we recommend completing one session per week. It includes psychoeducational content and exercises that are based on empirically validated intervention tools, mainly issued from Cognitive-Behavioral Therapy but also from positive psychology and cognitive psychopathology frame.

Device: LIVIA

Interventions

LIVIADEVICE

The study aim to compare the efficacy of an IBI targeting complicated grief symptoms (LIVIA 2.0) compared to an already investigated IBI (LIVIA 1) using a guidance on demand design in a randomised controlled trial. Both programs are composed of 10 weekly sessions proposing educational material, questionnaires and exercises. They are based on current scientific theories of grief but present their content differently. Compared to LIVIA 1, LIVIA 2.0 is less based on academic readings and participants can choose more freely which topics and exercises they want to do. LIVIA 2.0 also offers a system of reminder messages to maximize adherence as well as more elaborate automated guidance.

LIVIA 1LIVIA 2.0

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Bereavement or separation/divorce
  • Either of these events should have happened more than 6 months before participating in the study
  • Feeling the need for support to cope with the loss (a diagnosis of complicated grief is not necessary)
  • Age: 18 years or older
  • Regular Internet access
  • Mastery of the French language - Approved ICF

You may not qualify if:

  • Moderate to acute current suicidality (SIDAS \> 19)
  • Severe psychological or somatic disorders which need immediate treatment.
  • Concomitant psychotherapy
  • Prescription or change in dosage of psychoactive drugs in the month prior or during the self-help intervention.
  • Inability to follow the procedures of the study, e.g. due to comprehension problems
  • Enrolment of the investigator, his/her family members, employees, and other dependent persons.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Lausanne - Institute of Psychology

Lausanne, Canton of Vaud, 1015, Switzerland

Location

Related Publications (2)

  • Debrot A, Efinger L, Kheyar M, Pomini V, Berthoud L. A French-Language Web-Based Intervention Targeting Prolonged Grief Symptoms in People Who Are Bereaved and Separated: Randomized Controlled Trial. JMIR Form Res. 2024 Oct 16;8:e57294. doi: 10.2196/57294.

  • Debrot A, Kheyar M, Efinger L, Berthoud L, Pomini V. Supporting People Who Have Lost a Close Person by Bereavement or Separation: Protocol of a Randomized Controlled Trial Comparing Two French-Language Internet-Based Interventions. JMIR Res Protoc. 2022 Jun 23;11(6):e39026. doi: 10.2196/39026.

Related Links

MeSH Terms

Conditions

Prolonged Grief Disorder

Condition Hierarchy (Ancestors)

Trauma and Stressor Related DisordersMental Disorders

Study Officials

  • Valentino Pomini

    University of Lausanne

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The study aim to compare the efficacy of an IBI targeting complicated grief symptoms (LIVIA 2.0) compared to an already investigated IBI (LIVIA 1) using a guidance on demand design in a randomised controlled trial. Both programs are composed of 10 weekly sessions proposing educational material, questionnaires and exercises. They are based on current scientific theories of grief but present their content differently. Compared to LIVIA 1, LIVIA 2.0 is less based on academic readings and participants can choose more freely which topics and exercises they want to do. LIVIA 2.0 also offers a system of reminder messages to maximize adherence as well as more elaborate automated guidance.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Sponsor-Investigator

Study Record Dates

First Submitted

December 23, 2021

First Posted

February 2, 2022

Study Start

May 6, 2022

Primary Completion

January 31, 2023

Study Completion

August 10, 2023

Last Updated

September 8, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will share

After publishing the results, the investigators will make the codified data available on request.

Shared Documents
STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
Access Criteria
The investigators demand that the purpose of the request is clearly stated.

Locations